145 related articles for article (PubMed ID: 37897815)
21. Barriers to Genetic Testing in Vascular Malformations.
Borst AJ; Hammill AM; Crary SE; McLean TW; Felton T; Blatt J
JAMA Netw Open; 2023 May; 6(5):e2314829. PubMed ID: 37219903
[TBL] [Abstract][Full Text] [Related]
22. AGA Clinical Practice Update on Young Adult-Onset Colorectal Cancer Diagnosis and Management: Expert Review.
Boardman LA; Vilar E; You YN; Samadder J
Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2415-2424. PubMed ID: 32525015
[TBL] [Abstract][Full Text] [Related]
23. Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access.
Shipman H; Flynn S; MacDonald-Smith CF; Brenton J; Crawford R; Tischkowitz M; ; Hulbert-Williams NJ
J Genet Couns; 2017 Dec; 26(6):1280-1291. PubMed ID: 28540621
[TBL] [Abstract][Full Text] [Related]
24. Attitudes toward genetic testing in patients with colorectal cancer.
Kinney AY; Choi YA; DeVellis B; Millikan R; Kobetz E; Sandler RS
Cancer Pract; 2000; 8(4):178-86. PubMed ID: 11898257
[TBL] [Abstract][Full Text] [Related]
25. Genetic counseling service delivery models: A study of genetic counselors' interests, needs, and barriers to implementation.
Boothe E; Greenberg S; Delaney CL; Cohen SA
J Genet Couns; 2021 Feb; 30(1):283-292. PubMed ID: 32885542
[TBL] [Abstract][Full Text] [Related]
26. Primary Care Implications of the Expanded National Guidelines for Germline Testing of Patients Previously Diagnosed with Colorectal Cancer.
Sorscher S
J Am Board Fam Med; 2023 Apr; 36(2):360-365. PubMed ID: 36801845
[TBL] [Abstract][Full Text] [Related]
27. Impact of Health Insurance, Poverty, and Comorbidities on Colorectal Cancer Screening: Insights from the Medical Expenditure Panel Survey.
Gawron AJ; Staub J; Bielefeldt K
Dig Dis Sci; 2021 Jan; 66(1):70-77. PubMed ID: 32816210
[TBL] [Abstract][Full Text] [Related]
28. Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non-Small Cell Lung Cancer and Colorectal Cancer.
Roberts TJ; Kehl KL; Brooks GA; Sholl L; Wright AA; Landrum MB; Keating NL
JAMA Netw Open; 2023 Apr; 6(4):e2310809. PubMed ID: 37115543
[TBL] [Abstract][Full Text] [Related]
29. A Survey of Provider Attitudes, Beliefs, and Perceived Barriers Regarding a Centralized Direct-Mail Colorectal Cancer Screening Approach at Community Health Centers.
Thompson JH; Schneider JL; Rivelli JS; Petrik AF; Vollmer WM; Fuoco MJ; Coronado GD
J Prim Care Community Health; 2019; 10():2150132719890950. PubMed ID: 31779517
[No Abstract] [Full Text] [Related]
30. Colorectal Cancer Screening in Ghana: Physicians' Practices and Perceived Barriers.
Lussiez A; Dualeh SHA; Dally CK; Opoku BK; Raghavendran K; Aitpillah F; Boateng E; Darkwah D; Gyasi-Sarpong KC; Kolars JC; Kwakye G
World J Surg; 2021 Feb; 45(2):390-403. PubMed ID: 33145608
[TBL] [Abstract][Full Text] [Related]
31. Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing.
Wang Y; Golesworthy B; Cuggia A; Domecq C; Chaudhury P; Barkun J; Metrakos P; Asselah J; Bouganim N; Gao ZH; Chong G; Foulkes WD; Zogopoulos G
J Med Genet; 2022 Aug; 59(8):793-800. PubMed ID: 34556502
[TBL] [Abstract][Full Text] [Related]
32. Impact of academic affiliation and training on knowledge of hereditary colorectal cancer.
Chan V; Blazey W; Tegay D; Harper B; Koehler S; Laurent B; Lipka S; Cohn J; Jung MK; Krishnamachari B
Public Health Genomics; 2014; 17(2):76-83. PubMed ID: 24458016
[TBL] [Abstract][Full Text] [Related]
33. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM
J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158
[TBL] [Abstract][Full Text] [Related]
34. Implementation of a novel program to support colorectal cancer screening in a community health center consortium before and after the onset of COVID-19: a qualitative study of stakeholders' perspectives.
Santiago-Rodríguez EJ; Hoeft KS; Lugtu K; McGowen M; Ofman D; Adler J; Somsouk M; Potter MB
Implement Sci Commun; 2023 May; 4(1):54. PubMed ID: 37218022
[TBL] [Abstract][Full Text] [Related]
35. Genetics and Genetic Testing in Hereditary Colorectal Cancer.
Stoffel EM; Boland CR
Gastroenterology; 2015 Oct; 149(5):1191-1203.e2. PubMed ID: 26226567
[TBL] [Abstract][Full Text] [Related]
36. Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer.
Seagle HM; Keller SR; Tavtigian SV; Horton C; Holowatyj AN
J Clin Oncol; 2023 Sep; 41(26):4279-4289. PubMed ID: 37319387
[TBL] [Abstract][Full Text] [Related]
37. Cost-Effectiveness of Colorectal Cancer Genetic Testing.
Ramdzan AR; Manaf MRA; Aizuddin AN; Latiff ZA; Teik KW; Ch'ng GS; Ganasegeran K; Aljunid SM
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444091
[TBL] [Abstract][Full Text] [Related]
38. Somatic mismatch repair testing in evaluation of Lynch syndrome: The gap between preferred and current practices.
Williams D; Vilar E; Shakrukh Hashmi S; Choates M; Noblin S; Mork M
J Genet Couns; 2020 Oct; 29(5):728-736. PubMed ID: 31896172
[TBL] [Abstract][Full Text] [Related]
39. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
[TBL] [Abstract][Full Text] [Related]
40. Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.
Deverka PA; Schully SD; Ishibe N; Carlson JJ; Freedman A; Goddard KA; Khoury MJ; Ramsey SD
Genet Med; 2012 Jul; 14(7):656-62. PubMed ID: 22481130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
